Drug Shortage Report for AURO-OLMESARTAN HCTZ

Last updated on 2025-01-16 History
Report ID 106080
Drug Identification Number 02476487
Brand name AURO-OLMESARTAN HCTZ
Common or Proper name Hydrochlorothiazide; Olmesartan Medoxil
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL
Strength(s) 12.5MG 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-11-15
Estimated end date 2024-12-15
Actual end date 2025-01-15
Shortage status Resolved
Updated date 2025-01-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v50 2025-01-16 English Compare
v49 2024-12-16 French Compare
v48 2024-12-16 English Compare
v47 2024-10-25 French Compare
v46 2024-10-25 English Compare
v45 2024-10-11 French Compare
v44 2024-10-11 English Compare
v43 2024-09-27 French Compare
v42 2024-09-27 English Compare
v41 2024-09-13 French Compare
v40 2024-09-13 English Compare
v39 2024-08-13 French Compare
v38 2024-08-13 English Compare
v37 2024-07-29 French Compare
v36 2024-07-29 English Compare
v35 2024-07-15 French Compare
v34 2024-07-15 English Compare
v33 2024-05-30 French Compare
v32 2024-05-30 English Compare
v31 2024-04-25 French Compare

Showing 1 to 20 of 50